United States Últimas notícias

Intensity Therapeutics (NASDAQ:INTS) restarted dosing in its 61-patient INVINCIBLE-4 trial, testing INT230-6 before standard treatment for presurgical TNBC.

Halliburton (NYSE:HAL) announced it secured a multi-year contract from Aramco to support unconventional gas development programs in Saudi Arabia.

Morgan Stanley's stock traders beat expectations to set another quarterly record as the firm earned $6.3 billion from equity trading in the period, a 69% jump that topped its previous all-time high from the first quarter. Jonathan Ferro and Lisa Abramowicz examine the results on "Bloomberg Surveillance."

Sify Technologies (NASDAQ:SIFY) reported Q1 FY2026-27 revenue of ₹12.352 billion, up 15%, with a ₹65 million profit.

Kaspi.kz (NASDAQ:KSPI) announced it completed the acquisition of Rabobank A.Ş. to expand its digital banking operations for its regional network of 25 million consumers.

Conagra Brands (NYSE:CAG) reported Q4 fiscal 2026 net sales of $2.9 billion, a diluted loss of $3.37 per share and an annualized dividend cut to $0.70.

Morgan Stanley (NYSE:MS) reported record Q2 2026 net revenue of $21.3 billion and diluted EPS of $3.46 as its major business divisions expanded.

Bruker (NASDAQ:BRKR) acquired DISQVER, an mNGS platform that can analyze blood-derived cell-free DNA for more than 11,000 microbes within 24 hours.

Axsome Therapeutics (NASDAQ:AXSM) announced the FDA accepted its New Drug Application for narcolepsy treatment AXS-12, setting a 2027 target date.

Veradermics (NYSE:MANE) reported that its VDPHL01 treatment produced an average increase of up to 23.3 hairs per square centimeter in female patients over six months.

Highway Holdings (NASDAQ:HIHO) reported fiscal 2026 revenue of $4.8 million and a shareholder-attributable net loss of $1.5 million, or $0.33 per share.

Dubai-based property tycoon Mohamed Alabbar is planning two large-scale housing and tourism developments in Syria worth at least $20 billion. He spoke to Bloomberg's Zainab Fattah.